McClure L, Eccleshall T R, Gross C, Villa M L, Lin N, Ramaswamy V, Kohlmeier L, Kelsey J L, Marcus R, Feldman D
Department of Medicine, Stanford University School of Medicine, CA, USA.
J Bone Miner Res. 1997 Feb;12(2):234-40. doi: 10.1359/jbmr.1997.12.2.234.
Common polymorphisms in the vitamin D receptor (VDR) gene have been shown to correlate with bone mineral density (BMD). However, attempts to replicate the original findings in other populations have yielded variable results. These disparities may reflect ethnic or environmental differences in the expression of the VDR effect upon BMD. We examined a relatively ethnically homogeneous group of 103 healthy postmenopausal Caucasian women of Mexican descent living in Northern California. We determined the VDR genotype and measured the BMD at the lumbar spine and femoral neck by dual-energy X-ray absorptiometry, as well as several biochemical indices of mineral metabolism. The prevalence of the BB genotype, associated in previous studies with the lowest BMD, was 8% and highly linked to the tt genotype. Absolute and age-adjusted BMD at both hip and spine showed a trend toward lower BMD in the BB, AA, and tt genotypes, but this trend did not achieve statistical significance. There were no consistent intergroup differences in change in BMD over 2 years of follow-up, nor in mean serum concentrations of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, osteocalcin, or total urinary pyridinolines. Intact parathyroid hormone concentrations were significantly higher in subjects with the AA genotype, with a trend toward higher values in those with the BB and tt genotypes as well. Our data suggest that there may be a decrease in BMD associated with the B, A, and t alleles, but the intergroup difference in BMD is 0.2-0.5 standard deviations (SD) at the lumbar spine and 0.3 SD at the femoral neck, decreases that are smaller than previously reported. Given the relatively low prevalence of the BB/tt genotype in Mexican-American Caucasians, a larger sample would be required to detect a significant association between VDR alleles and differences in BMD of the magnitude suggested by our data. We conclude that a genotype effect of this magnitude, if present, would be clinically relevant, but the impact on BMD is too small to detect with statistical significance in a study of this size.
维生素D受体(VDR)基因的常见多态性已被证明与骨密度(BMD)相关。然而,在其他人群中重复最初研究结果的尝试却产生了不同的结果。这些差异可能反映了VDR对BMD影响的表达在种族或环境上的差异。我们研究了居住在北加利福尼亚的103名健康的墨西哥裔绝经后白种女性,她们在种族上相对同质。我们确定了VDR基因型,并通过双能X线吸收法测量了腰椎和股骨颈的骨密度,以及几种矿物质代谢的生化指标。BB基因型的患病率为8%,在先前研究中与最低骨密度相关,且与tt基因型高度连锁。髋部和脊柱的绝对骨密度和年龄校正骨密度在BB、AA和tt基因型中均呈现出骨密度较低的趋势,但这一趋势未达到统计学显著性。在2年的随访中,骨密度变化的组间差异不一致,25-羟基维生素D、1,25-二羟基维生素D、骨钙素或总尿吡啶啉的平均血清浓度组间差异也不一致。AA基因型受试者的完整甲状旁腺激素浓度显著更高,BB和tt基因型受试者也有升高的趋势。我们的数据表明,与B、A和t等位基因相关的骨密度可能会降低,但腰椎的组间骨密度差异为0.2 - 0.5个标准差(SD),股骨颈为0.3 SD,这些降低幅度小于先前报道。鉴于墨西哥裔美国白种人中BB/tt基因型的患病率相对较低,需要更大的样本量才能检测到VDR等位基因与我们数据所提示的骨密度差异之间的显著关联。我们得出结论,这种程度的基因型效应(如果存在)在临床上是相关的,但对骨密度的影响太小,在本规模的研究中无法检测到统计学显著性。